中文 | English
Return
Total: 225 , 1/23
Show Home Prev Next End page: GO
Author:(Jing-Kai XU)

1.EUS elastographic patterns of normal pancreas and focal pancreatic lesions

Kai XU ; Dabin REN ; Xiaomin SUN ; Jing WANG ; Ping XU

Chinese Journal of Digestive Endoscopy 2010;27(9):461-464

2.Effect of Agonist and Inhibitor of PI3K/AKT on Inflammatory Response in Macrophages

Jing WANG ; Ping XU ; Zhiwen YANG ; Kai XU ; Yuexing LAI

Chinese Journal of Gastroenterology 2017;22(2):82-86

3.The clinical value of artificial pleural effusion for percutaneous microwave ablation of liver cancer in the hepatic dome

Aohua ZHANG ; Jing XU ; Kai LI ; Zhongzhen SU

The Journal of Practical Medicine 2014;(18):2961-2963

4.A comparative study on accommodative microfluctuation between emmetropic and myopic school-aged children

Kai, DIAO ; Jing-jing, XU ; Zhi-li, ZHENG ; Jin-hua, BAO ; Hao, CHEN

Chinese Journal of Experimental Ophthalmology 2013;(6):555-558

5.Effect of pioglitazone on PPARγ mRNA expression in rats with acute necrotizing pancreatitis

Ping XU ; Qinghua LI ; Jing WANG ; Kai XU ; Jingping JIANG ; Lingquan CHEN

Chinese Journal of Pancreatology 2010;10(5):352-354

6.Research progress in characteristics of conjunctiva goblet cells and its relationship with ocular surface health

Yu, ZHONG ; Ji-Kai, ZHU ; Lu-Xuan, WANG ; Jing-Dong, XU

International Eye Science 2017;17(9):1667-1670

8.Relationship between polymorphisms of CX3CR1 gene and coronary artery disease: a Meta-analysis

Wenlong LI ; Xiaojian WANG ; Jing XU ; Jingzhou CHEN ; Channa ZHANG ; Kai SUN ; Rutai HUI

Basic & Clinical Medicine 2009;29(11):1170-1173

10.Effect of Postasphyxial-Serum in Neonate on the Expressions of Bcl-2-Antagonist of Cell Death and Bcl-2-Associated X Protein in Renal Tubular Cells

jing, ZHAO ; wen-bin, DONG ; ming-yong, WANG ; cun-liang, DENG ; feng, CHEN ; kai-gui, XU

Journal of Applied Clinical Pediatrics 1986;0(02):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 225 , 1/23 Show Home Prev Next End page: GO